Davis CD, Milner J, 2004, Frontiers in Nutrigenomics, Proteomics, Metabolomics and Cancer Prevention. Mutat Res, 551:51–64.

Hassanpour SH, Dehghani M, 2017, Review of Cancer from Perspective of Molecular. J Cancer Res Pract, 4:127–9.

Sarkar FH, Li Y, Wang Z, et al., 2010, The Role of Nutraceuticals in the Regulation of Wnt and Hedgehog Signaling in Cancer. Cancer Metastasis Rev, 29:383–94. DOI: 1007/s10555-010-9233-4.

Wang W, Pan Y, Zhou H, et al., 2018, Ferulic Acid Suppresses Obesity and Obesity-Related Metabolic Syndromes in High Fat Diet-Induced Obese C57BL/6J Mice. Food Agric Immunol, 29:1116–25. DOI: 1080/09540105.2018.1516739.

Matsuno Y, Atsumi Y, Alauddin M, et al., 2020, Resveratrol and its Related polyphenols contribute to the Maintenance of Genome Stability. Sci Rep, 10:5388.

Phillips CM, 2013, Nutrigenetics and Metabolic Disease: Current Status and Implications for Personalised Nutrition. Nutrients, 5:32–57. DOI: 10.3390/nu5010032.

Udenigwe CC, Rouvinen-Watt K, 2015, The Role of Food Peptides in Lipid Metabolism During Dyslipidemia and Associated Health Conditions. Int J Mol Sci, 16:9303–13. DOI: 10.3390/ijms16059303.

Magrone T, Panaro MA, Jirillo E, et al., 2008, Molecular Effects Elicited In Vitro by Red Wine on Human Healthy Peripheral Blood Mononuclear Cells: Potential Therapeutical Application of Polyphenols to Diet-Related Chronic Diseases. Curr Pharm Des, 14:2758–66. DOI: 10.2174/138161208786264179.

Gautam SP, 2013, Nutraceuticals: A Boom to Medical Industry. Res Gate Pharm Sci, 2:1–8.

Brennan RO, Mulligan WC, 1975, Nutrigenetics: New Concepts for Relieving Hypoglycemia: Case Studies. Vermont Avenue: M Evans and Company.

Fenech M, El-Sohemy A, Cahill L, et al., 2011, Nutrigenetics and Nutrigenomics: Viewpoints on the Current Status and Applications in Nutrition Research and Practice. J Nutrigenet Nutrigenomics, 4:69–89. DOI: 10.1159/000327772.

Hussain SS, Kumar AP, Ghosh R, 2016, Food-Based Natural Products for Cancer Management: Is the Whole Greater than the Sum of the Parts? In: Seminars in Cancer Biology. Vol. 40. Cambridge, Massachusetts: Academic Press. pp233-246. DOI: 10.1016/j.semcancer.2016.06.002.

Piroddi M, Albini A, Fabiani R, et al., 2017, Nutrigenomics of Extra‐virgin Olive Oil: A Review. Biofactors, 43:17–41. DOI: 10.1002/biof.1318.

Dandawate PR, Subramaniam D, Jensen RA, et al., 2016, Targeting Cancer Stem Cells and Signaling Pathways by Phytochemicals: Novel Approach for Breast Cancer Therapy. In: Seminars in Cancer Biology. Vol. 40. Cambridge, Massachusetts: Academic Press. pp.192–208. DOI: 10.1016/j.semcancer.2016.09.001.

Marcum JA, 2020, Nutrigenetics/Nutrigenomics, Personalized Nutrition, and Precision Healthcare. Curr Nutr Rep, 9:338–45. DOI: 10.1016/j.semcancer.2016.09.001.

Ferguson LR, De Caterina R, Görman U, et al., 2016, Guide and Position of the International Society of Nutrigenetics/Nutrigenomics on Personalised Nutrition: Part 1-Fields of Precision Nutrition. J Nutrigenet Nutrigenomics, 9:12–27. DOI: 10.1159/000446347.

Cornelis MC, 2012, Coffee Intake. Prog Mol Biol Transl Sci, 108:293–322.

Rizzi F, Conti C, Dogliotti E, et al., 2016, Interaction between Polyphenols Intake and PON1 Gene Variants on Markers of Cardiovascular Disease: A Nutrigenetic Observational Study. J Transl Med, 14:186. DOI: 10.1186/s12967-016-0941-6.

Nguyen-Tu MS, da Silva Xavier G, Leclerc I, et al., 2018, Transcription Factor-7-Like 2 (TCF7L2) Gene Acts Downstream of the Lkb1/Stk11 Kinase to Control mTOR Signaling, b Cell Growth, and Insulin Secretion. J Biol Chem, 293:14178–89. DOI: 10.1074/jbc.ra118.003613.

Sales NM, Pelegrini PB, Goersch MC, 2014, Nutrigenomics: Definitions and Advances of this New Science. J Nutr Metab, 2014:202759.

Kussmann M, van Bladeren P, 2011, The Extended Nutrigenomics-Understanding the Interplay between the Genomes of Food, Gut Microbes, and Human Host. Front Genet, 2:21. DOI: 10.3389/fgene.2011.00021.

Iacoviello L, Santimone I, Latella MC, et al., 2008, Nutrigenomics: A Case for the Common Soil between Cardiovascular Disease and Cancer. Genes Nutr, 3:19–24. DOI: 10.1007/s12263-008-0079-0.

Laddu D, Hauser M, 2019, Addressing the Nutritional Phenotype through Personalized Nutrition for Chronic Disease Prevention and Management. Prog Cardiovasc Dis, 62:9–14. DOI: 10.1016/j.pcad.2018.12.004.

Harbison CE, Lipman RD, Bronson RT, 2016, Strain-and Diet-related Lesion Variability in aging DBA/2, C57BL/6, and DBA/2xC57BL/6 F1 Mice. Vet Pathol, 53:468–76. DOI: 10.1177/0300985815612152.

Kurin E, Atanasov AG, Donath O, et al., 2012, Synergy Study of the Inhibitory Potential of Red Wine Polyphenols on Vascular Smooth Muscle Cell Proliferation. Plant Med, 78:772–8. DOI: 10.1055/s-0031-1298440.

Bylsma LC, Alexander DD, 2015, A Review and Meta-analysis of Prospective Studies of Red and Processed Meat, Meat Cooking Methods, Heme Iron, Heterocyclic Amines and Prostate Cancer. Nutr J, 14:125. DOI: 10.1186/s12937-015-0111-3.

Irimie AI, Braicu C, Cojocneanu-Petric R, et al., 2015, Novel Technologies for Oral Squamous Carcinoma Biomarkers in Diagnostics and Prognostics. Acta Odontol Scand, 73:161–8. DOI: 10.3109/00016357.2014.986754.

Ni CX, Gong H, Liu Y, et al., 2017, Green Tea Consumption and the Risk of Liver Cancer: A Meta-Analysis. Nutr Cancer, 69:211–20.

Fei X, Shen Y, Li X, et al., 2014, The Association of Tea Consumption and the Risk and Progression of Prostate Cancer: A Meta-Analysis. Int J Clin Exp Med, 7:3881.

Verrax J, Calderon PB, 2008, The Controversial Place of Vitamin C in Cancer Treatment. Biochem Pharmacol, 76:1644–52. DOI: 10.1016/j.bcp.2008.09.024.

Duthie SJ, 2011, Folate and Cancer: How DNA Damage, Repair and Methylation Impact on Colon Carcinogenesis. J Inherit Metab Dis, 34:101–9. DOI: 10.1007/s10545-010-9128-0.

Azrad M, Turgeon CE, Demark-Wahnefried W, 2013, Current Evidence Linking Polyunsaturated Fatty Acids with Cancer Risk and Progression. Front Oncol, 3:224. DOI: 10.3389/fonc.2013.00224.

Li M, Zhou J, Gu X, et al., 2009, Quantitative Capillary Electrophoresis and its Application in Analysis of Alkaloids in Tea, Coffee, Coca Cola, and Theophylline Tablets. J Sep Sci, 32:267–74. DOI: 10.1002/jssc.200800529.

Kuršvietienė L, Mongirdienė A, Bernatonienė J, et al., 2002, Selenium Anti-cancer Properties and Impact on Cellular Redox Status. Antioxidants, 9:80. DOI: 10.3390/antiox9010080.

Ramoutar RR, Brumaghim JL, 2010, Antioxidant and Anti-cancer Properties and Mechanisms of Inorganic Selenium, Oxo-sulfur, and Oxo-selenium Compounds. Cell Biochem Biophys, 58(1):1–23. DOI: 10.1007/s12013-010-9088-x.

Pieroth R, Paver S, Day S, et al., 2018, Folate and its Impact on Cancer Risk. Curr Nutr Rep, 7:70–84. DOI: 10.1007/s13668-018-0237-y.

Palmer S, 1985, Diet, Nutrition, and Cancer. Prog Food Nutr Sci, 9:283–341.

Tessitore A, Mastroiaco V, Vetuschi A, et al., 2017, Development of Hepatocellular Cancer Induced by Long Term Low Fat-High Carbohydrate Diet in a NAFLD/NASH Mouse Model. Oncotarget, 8:53482. DOI: 10.18632/oncotarget.18585.

Mohammed SG, Bossa S, Qoronfleh MW, 2020, Grains. In: Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management. Cham: Springer. pp.377–394. DOI: 10.1007/978-3-030-30402-7_11.

Viguerie N, Poitou C, Cancello R, et al., 2005, Transcriptomics Applied to Obesity and Caloric Restriction. Biochimie, 87:117–23. DOI: 10.1016/j.biochi.2004.12.011.

Gu Z, Suburu J, Chen H, et al., 2013, Mechanisms of Omega-3 Polyunsaturated Fatty Acids in Prostate Cancer Prevention. Biomed Res Int, 2013:824563. DOI: 10.1155/2013/824563.

Sun J, 2007, D-Limonene: Safety and Clinical Applications. Altern Med Rev, 12(3):259.

Milner JA, 2001, Mechanisms by which Garlic and Allyl Sulfur Compounds Suppress Carcinogen Bioactivation. In: Nutrition and Cancer Prevention. Boston, MA: Springer, pp.69-81. DOI: 10.1007/978-1-4615-1283-7_7.

Shen G, Khor TO, Hu R, et al., 2007, Chemoprevention of Familial Adenomatous Polyposis by Natural Dietary Compounds Sulforaphane and Dibenzoylmethane Alone and in Combination in ApcMin/+ Mouse. Cancer Res, 67:9937–44. DOI: 10.1158/0008-5472.can-07-1112.

Gustin DM, Rodvold KA, Sosman JA, et al., 2004, Single-dose Pharmacokinetic Study of Lycopene Delivered in a Well-defined Food-based Lycopene Delivery System (Tomato Paste-oil Mixture) in Healthy Adult Male Subjects. Cancer Epidemiol Prev Biomark, 13:850–60.

Kao YH, Hiipakka RA, Liao S, 2000, Modulation of Endocrine Systems and Food Intake by Green Tea Epigallocatechin Gallate. Endocrinology, 141:980–7. DOI: 10.1210/endo.141.3.7368.

Pathy NB, Peeters P, Van Gils C, et al., 2010, Coffee and Tea Intake and Risk of Breast Cancer. Breast Cancer Res Treatment, 121:461–7. DOI: 10.1007/s10549-009-0583-y.

Wang N, Wang Q, Tang H, et al., 2017, Direct Inhibition of ACTN4 by Ellagic Acid Limits Breast Cancer Metastasis Via Regulation of b-Catenin Stabilization in Cancer Stem Cells. J Exp Clin Cancer Res, 36:1–9. DOI: 10.1186/s13046-017-0635-9.

Hua X, Yu L, You R, et al., 2016, Association among Dietary Flavonoids, Flavonoid Subclasses and Ovarian Cancer Risk: A Meta-Analysis. PLoS One, 11:e0151134. DOI: 10.1371/journal.pone.0151134.

Braakhuis AJ, Campion P, Bishop KS, 2016, Reducing Breast Cancer Recurrence: the Role of Dietary Polyphenolics. Nutrients, 8:547. DOI: 10.3390/nu8090547.

Hui C, Qi X, Qianyong Z, et al., 2013, Flavonoids, Flavonoid Subclasses and Breast Cancer Risk: A Meta-Analysis of Epidemiologic Studies. PLoS One, 8:e54318. DOI: 10.1371/journal.pone.0054318.

Wei Y, Lv J, Guo Y, et al., 2020, Soy Intake and Breast Cancer Risk: A Prospective Study of 300,000 Chinese Women and a Dose Response Meta-Analysis. Eur J Epidemiol, 35:567–78.

Baglia ML, Zheng W, Li H, et al., 2016, The Association of Soy Food Consumption with the Risk of Subtype of Breast Cancers Defined by Hormone Receptor and HER2 Status. Int J Cancer, 139:742–8. DOI: 10.1002/ijc.30117.

Link A, Balaguer F, Goel A, 2010, Cancer Chemoprevention by Dietary Polyphenols: Promising Role for Epigenetics. Biochem Pharmacol, 80:1771–92. DOI: 10.1016/j.bcp.2010.06.036.

Leri M, Scuto M, Ontario ML, et al., 2020, Healthy Effects of Plant Polyphenols: Molecular Mechanisms. Int J Mol Sci, 21:1250. DOI: 10.3390/ijms21041250.

Greenwald P, Milner JA, Anderson DE, et al., 2002, Micronutrients in Cancer Chemoprevention. Cancer Metastasis Rev, 21:217–30.

Benetou V, Lagiou A, Lagiou P, 2015, Chemoprevention of Cancer: Current Evidence and Future Prospects. F1000Research, 4:916. DOI: 10.12688/f1000research.6684.1.

Taibi A, Lin Z, Tsao R, et al., 2019, Effects of Flaxseed and its Components on Mammary Gland MiRNome: Identification of Potential Biomarkers to Prevent Breast Cancer Development. Nutrients, 11:2656. DOI: 10.3390/nu11112656.

Choi HS, Cho MC, Lee HG, et al., 2010, Indole-3-Carbinol Induces Apoptosis through p53 and Activation of Caspase-8 Pathway in Lung Cancer A549 Cells. Food Chem Toxicol, 48:883–90. DOI: 10.1016/j.fct.2009.12.028.

Abbaoui B, Telu KH, Lucas CR, et al., 2017, The Impact of Cruciferous Vegetable Isothiocyanates on Histone Acetylation and Histone Phosphorylation in Bladder Cancer. J Proteomics, 156:94–103. DOI: 10.1016/j.jprot.2017.01.013.

Kan SF, Wang J, Sun GX, 2018, Sulforaphane Regulates Apoptosis-and Proliferation-related Signaling Pathways and Synergizes with Cisplatin to Suppress Human Ovarian Cancer. Int J Mol Med, 42:2447–58. DOI: 10.3892/ijmm.2018.3860.

Zhang W, Ha M, Gong Y, et al., 2010, Allicin Induces Apoptosis in Gastric Cancer Cells Through Activation of Both Extrinsic and Intrinsic Pathways. Oncol Rep, 24:1585–92. DOI: 10.3892/or_00001021.

Rawangkan A, Wongsirisin P, Namiki K, et al., 2018, Green Tea Catechin is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth. Molecules, 23:2071. DOI: 10.3390/molecules23082071.

Bułdak RJ, Hejmo T, Osowski M, et al., 2018, The Impact of Coffee and its Selected Bioactive Compounds on the Development and Progression of Colorectal Cancer In Vivo and In Vitro. Molecules, 23:3309. DOI: 10.3390/molecules23123309.

Hashemi-Niasari F, Rabbani-Chadegani A, Razmi M, et al., 2018, Synergy of Theophylline Reduces Necrotic Effect of Berberine, Induces Cell Cycle Arrest and PARP, HMGB1, Bcl-2 Family Mediated Apoptosis in MDA-MB-231 Breast Cancer Cells. Biomed Pharmacother, 106:858–67. DOI: 10.1016/j.biopha.2018.07.019.

Applegate CC, Rowles JL, Ranard KM, et al., 2018, Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-analysis. Nutrients, 10:40. DOI: 10.3390/nu10010040.

Li YT, Tian XT, Wu ML, et al., 2018, Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells. Int J Mol Sci, 19:1030. DOI: 10.3390/ijms19041030.

Mannal PW, Alosi JA, Schneider JG, et al., 2010, Pterostilbene Inhibits Pancreatic Cancer In Vitro. J Gastrointest Surg, 14:873–9. DOI: 10.1007/s11605-010-1164-4.

Rabi T, Bishayee A, 2009, d-Limonene Sensitizes Docetaxel-Induced Cytotoxicity in Human Prostate Cancer Cells: Generation of Reactive Oxygen Species and Induction of Apoptosis. J Carcinog, 8:9. DOI: 10.4103/1477-3163.51368.

Vinceti M, Rovesti S, Bergomi M, et al., 2000, The Epidemiology of Selenium and Human Cancer. Tumori J, 86:105–18. DOI: 10.1177/030089160008600201.

Weissenborn A, Ehlers A, Hirsch-Ernst KI, et al., 2017, A Two-faced Vitamin: Folic Acid-prevention or Promotion of Colon Cancer? Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 60:332–40. DOI: 10.1007/s00103-016-2505-6.

Singh V, San Yeoh B, Chassaing B, et al., 2018, Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer. Cell, 175:679–94.

Eslami M, Yousefi B, Kokhaei P, et al., 2019, Importance of Probiotics in the Prevention and Treatment of Colorectal Cancer. J Cell Physiol, 234:17127–43. DOI: 10.1002/jcp.28473.

Huang PL, 2009, A Comprehensive Definition for Metabolic Syndrome. Dis Model Mech, 2:231–7.

Lamb RE, Goldstein BJ, 2008, Modulating an Oxidative‐Inflammatory Cascade: Potential New Treatment Strategy for Improving Glucose Metabolism, Insulin Resistance, and Vascular Function. Int J Clin Pract, 62:1087–95. DOI: 10.1111/j.1742-1241.2008.01789.x.

Kern HJ, Mitmesser SH, 2018, Role of Nutrients in Metabolic Syndrome: A 2017 Update. Nutr Dietary Suppl, 10:13–26. DOI: 10.2147/nds.s148987.

Baumgard LH, Hausman GJ, Fernandez MS, 2016, Insulin: Pancreatic Secretion and Adipocyte Regulation. Domest Anim Endocrinol, 54:76–84. DOI: 10.1016/j.domaniend.2015.07.001.

Amatruda M, Ippolito G, Vizzuso S, et al., 2019, Epigenetic Effects of n-3 LCPUFAs: A Role in Pediatric Metabolic Syndrome. Int J Mol Sci, 20:2118. DOI: 10.3390/ijms20092118.

Bhaswant M, Poudyal H, Brown L, 2015, Mechanisms of Enhanced Insulin Secretion And Sensitivity with n-3 Unsaturated Fatty Acids. J Nutr Biochem, 26:571–84. DOI: 10.1016/j.jnutbio.2015.02.001.

Rylander C, Sandanger TM, Engeset D, et al., 2014, Consumption of Lean Fish Reduces the Risk of Type 2 Diabetes Mellitus: A Prospective Population Based Cohort Study of Norwegian Women. PLoS One, 9:e89845. DOI: 10.1371/journal.pone.0089845.

Kim H, Park S, Yang H, et al., 2015, Association between Fish and Shellfish, and Omega-3 PUFAs Intake and CVD Risk Factors in Middle-Aged Female Patients with Type 2 Diabetes. Nutr Res Pract, 9:496–502. DOI: 10.4162/nrp.2015.9.5.496.

Kozlowska A, Szostak-Wegierek D, 2014, Flavonoids-Food Sources and Health Benefits. Rocz Państw Zakł Hig, 65:79-85.

Raman G, Avendano EE, Chen S, et al., 2019, Dietary Intakes of Flavan-3-ols and Cardiometabolic Health: Systematic Review and Meta-Analysis of Randomized Trials and Prospective Cohort Studies. Am J Clin Nutr, 110:1067–78. DOI: 10.1093/ajcn/nqz178.

Gardner CD, Trepanowski JF, Del Gobbo LC, et al., 2018, Effect of Low-fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association with Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial. JAMA, 319:667–79. DOI: 10.1001/jama.2018.0245.

Lahbib A, Ghodbane S, Sakly M, et al., 2014, Vitamins and Glucose Metabolism: The Role of Static Magnetic Fields. Int J Radiat Biol, 90:1240–5. DOI: 10.3109/09553002.2014.930537.

Whitfield P, Parry-Strong A, Walsh E, et al., 2016, The Effect of a Cinnamon-, Chromium-and Magnesium-Formulated Honey on Glycaemic Control, Weight Loss and Lipid Parameters in Type 2 Diabetes: An Open-label Cross-over Randomised Controlled Trial. Eur J Nutr, 55:1123–31. DOI: 10.1007/s00394-015-0926-x.

Francini-Pesenti F, Spinella P, Calò LA, 2019, Potential Role of Phytochemicals in Metabolic Syndrome Prevention and Therapy. Diabetes Metab Syndr Obes, 12:1987–2002. DOI: 10.2147/dmso.s214550.

Rizza S, Muniyappa R, Iantorno M, et al., 2011, Citrus Polyphenol Hesperidin Stimulates Production of Nitric Oxide in Endothelial Cells while Improving Endothelial Function and Reducing Inflammatory Markers in Patients with Metabolic Syndrome. J Clin Endocrinol Metab, 96:E782–92. DOI: 10.1210/jc.2010-2879.

Trak‐Smayra V, Paradis V, Massart J, et al., 2011, Pathology of the Liver in Obese and Diabetic ob/ob and db/db Mice Fed a Standard or High Calorie Diet. Int J Exp Pathol, 92:413–21. DOI: 10.1111/j.1365-2613.2011.00793.x.

Baur JA, Pearson KJ, Price NL, et al., 2006, Resveratrol Improves Health and Survival of Mice on a High-calorie Diet. Nature, 444:337–42.

Lagouge M, Argmann C, Gerhart-Hines Z, et al., 2006, Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1a. Cell, 127:1109–22. DOI: 10.1016/j.cell.2006.11.013.

Timmers S, Konings E, Bilet L, et al., 2011, Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans. Cell Metab, 14:612–22. DOI: 10.1016/j.cmet.2011.10.002.

Park SJ, Ahmad F, Philp A, et al., 2012, Resveratrol Ameliorates aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases. Cell, 148:421–33. DOI: 10.1016/j.cell.2012.01.017.

Juhasz B, Varga B, Gesztelyi R, et al., 2001, Resveratrol: A Multifunctional Cytoprotective Molecule. Curr Pharm Biotechnol, 11:810–8.

Holmes-McNary M, Baldwin AS, 2000, Chemopreventive Properties of Trans-resveratrol are Associated with Inhibition of Activation of the IkB Kinase. Cancer Res, 60:3477–83.

Xu F, Fan W, Wang W, et al., 2019, Effects of Omega-3 Fatty Acids on Metabolic Syndrome in Patients with Schizophrenia: A 12-Week Randomized Placebo-Controlled Trial. Psychopharmacology, 236 :1273–9. DOI: 10.1007/s00213-018-5136-9.

Rustan AC, Nenseter MS, Drevon CA, 1997, Omega-3 and Omega-6 Fatty Acids in the Insulin Resistance Syndrome. Lipid and Lipoprotein Metabolism and Atherosclerosis. Ann N Y Acad Sci, 827:310–26. DOI: 10.1111/j.1749-6632.1997.tb51844.x.

Marangoni F, Agostoni C, Borghi C, et al., 2002, Dietary Linoleic Acid and Human Health: Focus on Cardiovascular and Cardiometabolic Effects. Atherosclerosis, 292:90–8. DOI: 10.1016/j.atherosclerosis.2019.11.018.

Ganetzky RD, Falk MJ, 2018, 8-Year Retrospective Analysis of Intravenous Arginine Therapy for Acute Metabolic Strokes in Pediatric Mitochondrial Disease. Mol Genet Metab, 123:301–8. DOI: 10.1016/j.ymgme.2018.01.010.

Layman DK, Walker DA, 2006, Potential Importance of Leucine in Treatment of Obesity and the Metabolic Syndrome. J Nutr, 136:319S–23. DOI: 10.1093/jn/136.1.319s.

Jetté L, Harvey L, Eugeni K, et al., 2009, 4-Hydroxyisoleucine: A Plant-derived Treatment for Metabolic Syndrome. Curr Opin Investig Drugs, 10:353–8.

Cicero AF, Colletti A, Rosticci M, et al., 2016, Effect of Lactotripeptides (Isoleucine-Proline-Proline/Valine-Proline-Proline) on Blood Pressure and Arterial Stiffness Changes in Subjects with Suboptimal Blood Pressure Control and Metabolic Syndrome: A Double-Blind, Randomized, Crossover Clinical Trial. Metab Syndr Relat Disord, 14:161–6. DOI: 10.1089/met.2015.0093.

Ronis MJ, Chen Y, Badeaux J, et al., 2009, Dietary Soy Protein Isolate Attenuates Metabolic Syndrome in Rats Via Effects on PPAR, LXR, and SREBP Signaling. J Nutr, 139:1431–8. DOI: 10.3945/jn.109.107029.

Palanisamy N, Viswanathan P, Ravichandran MK, et al., 2010, Renoprotective and Blood Pressure-Lowering Effect of Dietary Soy Protein via Protein Kinase C b II Inhibition in a Rat Model of Metabolic Syndrome. Can J Physiol Pharmacol, 88:28–37. DOI: 10.1139/y09-110.

Burke AC, Sutherland BG, Telford DE, et al., 2018, Intervention with Citrus Flavonoids Reverses Obesity and Improves Metabolic Syndrome and Atherosclerosis in Obese Ldlr-/-Mice. J Lipid Res, 59:1714–28. DOI: 10.1194/jlr.m087387.

Bhandarkar NS, Brown L, Panchal SK, 2019, Chlorogenic Acid Attenuates High-Carbohydrate, High-Fat Diet-Induced Cardiovascular, Liver, and Metabolic Changes in Rats. Nutr Res, 62:78–88. DOI: 10.1016/j.nutres.2018.11.002.

Kodentsova VM, Risnik DV, Sharafetdinov KK, et al., 2019, Vitamins in Diet of Patients with Metabolic Syndrome. Ther Arch, 91:118–25. DOI: 10.26442/00403660.2019.02.000097.

Fang C, Wu W, Gu X, et al., 2019, Association of Serum Copper, Zinc and Selenium Levels with Risk of Metabolic Syndrome: A Nested Case-control Study of Middle-aged and Older Chinese Adults. J Trace Elem Med Biol, 52:209–15. DOI: 10.1016/j.jtemb.2018.12.017.

Prasad S, Gupta SC, Tyagi AK, 2017, Reactive Oxygen Species (ROS) and Cancer: Role of Antioxidative Nutraceuticals. Cancer Lett, 387:95–105. DOI: 10.1016/j.canlet.2016.03.042.

Kumar M, Nagpal R, Verma V, et al., 2013, Probiotic Metabolites as Epigenetic Targets in the Prevention of Colon Cancer. Nutr Rev, 71:23–34. DOI: 10.1111/j.1753-4887.2012.00542.x.

He S, Yu Q, He Y, et al., 2019, Dietary Resveratrol Supplementation Inhibits Heat Stress-Induced High-Activated Innate Immunity and Inflammatory Response in Spleen of Yellow-Feather Broilers. Poult Sci, 98:6378–87. DOI: 10.3382/ps/pez471.

Wu H, Chen L, Zhu F, et al., 2019, The Cytotoxicity Effect of Resveratrol: Cell Cycle Arrest and Induced Apoptosis of BREAST CANCER 4T1 Cells. Toxins, 11:731. DOI: 10.3390/toxins11120731.

Buhrmann C, Shayan P, Goel A, et al., 2017, Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules. Nutrients, 9:1073. DOI: 10.3390/nu9101073.

Rauf A, Imran M, Butt MS, et al., 2018, Resveratrol as an Anti-cancer Agent: A Review. Crit Rev Food Sci Nutr, 58:1428–47.

Yang MF, Yao X, Chen LM, et al., 2002, Synthesis and Biological Evaluation of Resveratrol Derivatives with Anti‐breast Cancer Activity. Arch Pharm, 353:e2000044.

Ratnasinghe D, Tangrea JA, Andersen MR, et al., 2000, Glutathione Peroxidase Codon 198 Polymorphism Variant Increases Lung Cancer Risk. Cancer Res, 60:6381–3.

Tomlins SA, Laxman B, Varambally S, et al., 2008, Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer. Neoplasia, 10:177–88. DOI: 10.1593/neo.07822.

Duan J, Wu Y, Liu J, et al., 2019, Genetic Biomarkers for Hepatocellular Carcinoma in the Era of Precision Medicine. J Hepatocell Carcinoma, 6:151–66.

Testa U, Pelosi E, Castelli G, 2018, Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells. Med Sci, 6:31. DOI: 10.3390/medsci6020031.

Yong-Deok K, Eun-Hyoung J, Yeon-Sun K, et al., 2015, Molecular Genetic Study of Novel Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma. Med Oral Patol Oral Cirug, 20:e167. DOI: 10.4317/medoral.20229.

Jung CH, Hwang JY, Yu JH, et al., 2012, The Value of Apolipoprotein B/A1 Ratio in the Diagnosis of Metabolic Syndrome in a Korean Population. Clin Endocrinol, 77:699–706. DOI: 10.1111/j.1365-2265.2012.04329.x.

Tian Z, Li YL, Zhao L, et al., 2012, CYP2E1 RsaI/PstI Polymorphism and Liver Cancer Risk among East Asians: A HuGE Review and Meta-analysis. Asian Pac J Cancer Prev, 13:4915–21. DOI: 10.7314/apjcp.2012.13.10.4915.

Hidaka A, Sasazuki S, Matsuo K, et al., 2016, CYP1A1, GSTM1 and GSTT1 Genetic Polymorphisms and Gastric Cancer Risk among Japanese: A Nested Case Control Study within a Large Scale Population Based Prospective Study. Int J Cancer, 139:759–68. DOI: 10.1002/ijc.30130.

Komatsu Y, Aoyama K, Yoneda M, et al., 2020, The Prebiotic Fiber Inulin Ameliorates Cardiac, Adipose Tissue, and Hepatic Pathology but Exacerbates Hypertriglyceridemia in Rats with Metabolic Syndrome. Am J Physiol Heart Circ Physiol, 320:H281–95. DOI: 10.1152/ajpheart.00657.2020.

Huvenne H, Dubern B, Clément K, et al., 2016, Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016. Obes Facts, 9:158–73. DOI: 10.1159/000445061.

Paley CA, Johnson MI, 2018, Abdominal Obesity and Metabolic Syndrome: Exercise as Medicine? BMC Sports Sci Med Rehabil, 10:1–8. DOI: 10.1186/s13102-018-0097-1.

De Franco E, 2020, From biology to genes and back again: Gene discovery for monogenic forms of beta-cell dysfunction in diabetes. J Mol Biol, 432:1535–50. DOI: 10.1016/j.jmb.2019.08.016.

Ding L, Fan L, Xu X, et al., 2019, Identification of Core Genes and Pathways in Type 2 Diabetes Mellitus by Bioinformatics Analysis. Mol Med Rep, 20:2597–608.

Johansen CT, Wang J, Lanktree MB, et al., 2010, Excess of Rare Variants in Genes Identified by Genome-wide Association Study of Hypertriglyceridemia. Nat Genet, 42:684–7.

Thaker VV, 2017, Genetic and Epigenetic Causes of Obesity. Adolesc Med, 28:379–405.

Guo X, Cheng S, Taylor KD, et al., 2005, Hypertension Genes are Genetic Markers for Insulin Sensitivity and Resistance. Hypertension, 45:799–803.

Wheeler E, Huang N, Bochukova EG, et al., 2013, Genome-wide SNP and CNV Analysis Identifies Common and Low-Frequency Variants Associated with Severe Early-Onset Obesity. Nat Genet, 45:513–7. DOI: 10.1038/ng.2607.

Romero JD, Araujo RK, García AI, et al., 2015, ADIPOQ and ADIPOR2 Gene Polymorphisms: Association with Overweight/Obesity in Mexican Children. Bol Méd Hosp Infant Méx, 72:26–33.

Sesti G, 2000, Insulin Receptor Substrate Polymorphisms and Type 2 Diabetes Mellitus. Pharmacogenomics, 1:343–57. DOI: 10.1517/14622416.1.3.343.

Elks CM, Francis J, 2010, Central Adiposity, Systemic Inflammation, and the Metabolic Syndrome. Curr Hypertens Rep, 12:99–104. DOI: 10.1007/s11906-010-0096-4.

Gotoda T, 2004, Genetic Susceptibility to Metabolic Syndrome. Nihon Rinsho, 62:1037–44.

Hoffmann K, Mattheisen M, Dahm S, et al., 2007, A German Genome-Wide Linkage Scan for Type 2 Diabetes Supports the Existence of a Metabolic Syndrome Locus on Chromosome 1p36. 13 and a Type 2 Diabetes Locus on Chromosome 16p12. Diabetologia, 50:1418–22. DOI: 10.1007/s00125-007-0658-4.

Sanghera DK, Nath SK, Ortega L, et al., 2008, TCF7L2 Polymorphisms are Associated with Type 2 Diabetes in Khatri Sikhs from North India: Genetic Variation Affects Lipid Levels. Ann Hum Genet, 72:499–509. DOI: 10.1111/j.1469-1809.2008.00443.x.

Chan JC, Cheung JC, Stehouwer CD, et al., 2002, The Central Roles of Obesity-Associated Dyslipidaemia, Endothelial Activation and Cytokines in the Metabolic Syndrome an Analysis by Structural Equation Modelling. Int J Obes, 26:994–1008. DOI: 10.1038/sj.ijo.0802017.

Kraja AT, Chasman DI, North KE, et al., 2014, Pleiotropic Genes for Metabolic Syndrome and Inflammation. Mol Genet Metab, 112:317–38.

Wang H, Dong S, Xu H, et al., 2012, Genetic Variants in FTO Associated with Metabolic Syndrome: A Meta-and Gene-Based Analysis. Mol Biol Rep, 39:5691–8. DOI: 10.1007/s11033-011-1377-y.

Mattei J, Demissie S, Tucker KL, et al., 2009, Apolipoprotein A5 Polymorphisms Interact with Total Dietary fat Intake in Association with Markers of Metabolic Syndome in Puerto Rican Older Adults. J Nutr, 139:2301–8. DOI: 10.3945/jn.109.109900.

Levy H, Lamppu D, Anastosoaie V, et al., 2002, 5-Year Retrospective Analysis of Patients with Phenylketonuria (PKU) and Hyperphenylalaninemia Treated at Two Specialized Clinics. Mol Genet Metab, 129:177–85. DOI: 10.1016/j.ymgme.2019.12.007.

De Lucca M, Barba C, Casique L, 2017, A Novel Splicing Mutation in GALT Gene Causing Galactosemia in Ecuadorian Family. Clin Chim Acta, 470:20–3. DOI: 10.1016/j.cca.2017.04.021.

Muntoni S, Muntoni S, 2008, Gene-Nutrient Interactions in G6PD-Deficient Subjects-Implications for Cardiovascular Disease Susceptibility. J Nutrigenet Nutrigenomics, 1:49–54. DOI: 10.1159/000109874.